Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux
Multi-drug resistant tuberculosis (MDR-TB) represents a major health problem worldwide. Drug efflux and the activity of efflux transporters likely play important roles in the development of drug-tolerant and drug-resistant mycobacterial phenotypes. This study is focused on the action of a mycobacter...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2020.575828/full |
_version_ | 1818349697555759104 |
---|---|
author | Barbara De Siena Nicoletta Campolattano Gianluca D’Abrosca Luigi Russo Daire Cantillon Rosangela Marasco Lidia Muscariello Simon J. Waddell Margherita Sacco |
author_facet | Barbara De Siena Nicoletta Campolattano Gianluca D’Abrosca Luigi Russo Daire Cantillon Rosangela Marasco Lidia Muscariello Simon J. Waddell Margherita Sacco |
author_sort | Barbara De Siena |
collection | DOAJ |
description | Multi-drug resistant tuberculosis (MDR-TB) represents a major health problem worldwide. Drug efflux and the activity of efflux transporters likely play important roles in the development of drug-tolerant and drug-resistant mycobacterial phenotypes. This study is focused on the action of a mycobacterial efflux pump as a mechanism of drug resistance. Previous studies demonstrated up-regulation of the TetR-like transcriptional regulator MSMEG_3765 in Mycobacterium smegmatis and its ortholog Rv1685c in Mycobacterium tuberculosis (Mtb) in acid-nitrosative stress conditions. MSMEG-3765 regulates the expression of the MSMEG_3762/63/65 operon, and of the orthologous region in Mtb (Rv1687c/86c/85c). MSMEG-3762 and Rv1687c are annotated as ATP-binding proteins, while MSMEG-3763 and Rv1686c are annotated as trans-membrane polypeptides, defining an ABC efflux pump in both M. smegmatis and Mtb. The two putative efflux systems share a high percentage of identity. To examine the role of the putative efflux system MSMEG-3762/63, we constructed and characterized a MSMEG-3763 deletion mutant in M. smegmatis (∆MSMEG_3763). By comparative analysis of wild type, knockout, and complemented strains, together with structural modeling and molecular docking bioinformatics analyses of the MSMEG-3763 trans-membrane protein, we define the protein complex MSMEG-3762/63 as an efflux pump. Moreover, we demonstrate involvement of this pump in biofilm development and in the extrusion of rifampicin and ciprofloxacin (CIP), antimicrobial drugs used in first- and second-line anti-TB therapies. |
first_indexed | 2024-12-13T18:10:04Z |
format | Article |
id | doaj.art-f4407709c724465bb024ea2e121c693e |
institution | Directory Open Access Journal |
issn | 1664-302X |
language | English |
last_indexed | 2024-12-13T18:10:04Z |
publishDate | 2020-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Microbiology |
spelling | doaj.art-f4407709c724465bb024ea2e121c693e2022-12-21T23:35:58ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2020-12-011110.3389/fmicb.2020.575828575828Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug EffluxBarbara De Siena0Nicoletta Campolattano1Gianluca D’Abrosca2Luigi Russo3Daire Cantillon4Rosangela Marasco5Lidia Muscariello6Simon J. Waddell7Margherita Sacco8Dipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United KingdomDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United KingdomDipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, Caserta, ItalyMulti-drug resistant tuberculosis (MDR-TB) represents a major health problem worldwide. Drug efflux and the activity of efflux transporters likely play important roles in the development of drug-tolerant and drug-resistant mycobacterial phenotypes. This study is focused on the action of a mycobacterial efflux pump as a mechanism of drug resistance. Previous studies demonstrated up-regulation of the TetR-like transcriptional regulator MSMEG_3765 in Mycobacterium smegmatis and its ortholog Rv1685c in Mycobacterium tuberculosis (Mtb) in acid-nitrosative stress conditions. MSMEG-3765 regulates the expression of the MSMEG_3762/63/65 operon, and of the orthologous region in Mtb (Rv1687c/86c/85c). MSMEG-3762 and Rv1687c are annotated as ATP-binding proteins, while MSMEG-3763 and Rv1686c are annotated as trans-membrane polypeptides, defining an ABC efflux pump in both M. smegmatis and Mtb. The two putative efflux systems share a high percentage of identity. To examine the role of the putative efflux system MSMEG-3762/63, we constructed and characterized a MSMEG-3763 deletion mutant in M. smegmatis (∆MSMEG_3763). By comparative analysis of wild type, knockout, and complemented strains, together with structural modeling and molecular docking bioinformatics analyses of the MSMEG-3763 trans-membrane protein, we define the protein complex MSMEG-3762/63 as an efflux pump. Moreover, we demonstrate involvement of this pump in biofilm development and in the extrusion of rifampicin and ciprofloxacin (CIP), antimicrobial drugs used in first- and second-line anti-TB therapies.https://www.frontiersin.org/articles/10.3389/fmicb.2020.575828/fullmycobacteriaefflux pumpantimicrobial drugsmulti drug resistancebiofilmtransmembrane protein |
spellingShingle | Barbara De Siena Nicoletta Campolattano Gianluca D’Abrosca Luigi Russo Daire Cantillon Rosangela Marasco Lidia Muscariello Simon J. Waddell Margherita Sacco Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux Frontiers in Microbiology mycobacteria efflux pump antimicrobial drugs multi drug resistance biofilm transmembrane protein |
title | Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux |
title_full | Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux |
title_fullStr | Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux |
title_full_unstemmed | Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux |
title_short | Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux |
title_sort | characterization of the mycobacterial msmeg 3762 63 efflux pump in mycobacterium smegmatis drug efflux |
topic | mycobacteria efflux pump antimicrobial drugs multi drug resistance biofilm transmembrane protein |
url | https://www.frontiersin.org/articles/10.3389/fmicb.2020.575828/full |
work_keys_str_mv | AT barbaradesiena characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux AT nicolettacampolattano characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux AT gianlucadabrosca characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux AT luigirusso characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux AT dairecantillon characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux AT rosangelamarasco characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux AT lidiamuscariello characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux AT simonjwaddell characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux AT margheritasacco characterizationofthemycobacterialmsmeg376263effluxpumpinmycobacteriumsmegmatisdrugefflux |